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Abstract
Cancer is one of the leading causes of death for people in the United States. Despite the
numerous cancer treatments available, many of these chemotherapy treatments cause negative
side effects such as hair and weight loss. With this in mind, in the past 15 years, researchers have
discovered a mechanism known as RNA interference, which can be used to control certain genes
and their activity. This mechanism is based on the function of siRNA molecules, which can be
inserted into cells.(12) These siRNA molecules can be manipulated to target and eliminate specific
cancer cells. However, these siRNA molecules are normally associated with inconvenient
problems such as instability and a short half-life. These siRNA molecules also face an uphill task
of entering these targets cells. In most cases, cellular entryways are highly selective based on the
size and type of cargo.(1)(6) With this in mind, researchers have discovered that gold nanoparticles
(AuNPs) can be a suitable transport vehicle for siRNA molecules into targeted cells due to their
easy synthesis, easy modification for specific pathways, and high biocompatibility with living
tissue.(1)(2) Studies have shown that AuNPs can increase the half-life of siRNA molecules by six
fold. Before assembling these gold nanoparticles with siRNA, they must be coated with a reagent
of branched polyethyleneimine (C12-PEI) chains in order to increase the stability of the gold
nanoparticles, thus producing newly-formed AuPEI conjugates. Subsequently, the PEI will bind
with siRNA based on their electrostatic interaction, forming a well-dispersed nanoparticle with
uniform size and narrow size distribution.(8)
In Fall 2011, the Huang research group encountered several problems with the synthesis
of these AuPEI conjugates. These experiments revealed data suggesting that aggregation
occurred at certain concentrations of PEI. Experimental data also suggested that aggregation had
occurred when loading these AuPEI conjugates with tRNA. With these problems in mind, the
Spring 2012 semester of research has been geared towards determining the optimal PEI
concentration for the synthesis of AuPEI conjugates. More specifically, the research effort was
geared towards exploring how many PEI molecules are bound to each gold nanoparticle. The
Huang research group designed a C12PEI solution incorporated with fluorescein isothiocyanate
(FITC) in order to gain a closer look into the synthesis of these AuPEI-FITC conjugates. By
monitoring the fluorescence of these AuPEI-FITC conjugates, the results could provide
information about optimal synthesis conditions. The Huang research group has conducted
numerous experiments to study the effects of incubation time, temperature, and DTT
(dithiothreitol) concentration on the amount of PEI-FITC on each gold nanoparticle. Based on
the experimental results and its statistical analysis, the Huang research group has successfully
determined that an estimated 1,000 PEI molecules are bound to each gold nanoparticle. Upon
determining PEI density, the goal of the Summer 2012 semester was to optimize the AuPEItRNA conjugate assembly system. Based on extensive experimental data and analysis, the
optimized conditions for assembly have been established for future research efforts.
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Chapter 1: Problem Statement
In today’s world, cancer is one of the leading causes of death among the populations
throughout the United States. Cancer is characterized as a type of disease in which cells grow
exponentially, invade and kill healthy tissues in the body, and, in some cases, metastasize
throughout the body. According to the American Cancer Society, nearly 1.6 million deaths were
reported in the United States during 2011.(9) For many years, medical researchers have worked
countless hours in their laboratories, conducting experiments in order to discover new methods
that can effectively treat patients with cancer. Currently, there are hundreds of chemotherapy
treatments that can be used to inhibit the growth of cancer cells in the human body. While many
of these cancer treatments have been proven effective in the clinical settings, there are many
negative side effects associated with these chemotherapy treatments. On a positive note, most of
these treatments effectively inhibit and potentially eliminate the growth of cancer cells in the
human body. However, during this chemotherapeutic process, these treatments can also affect
healthy tissues of the body. Most commonly, cancer patients can experience hair loss, weight
loss, anemia, and fatigue when undergoing these chemotherapeutic treatments. Because of these
negative side effects, medical researchers suggest that there still is much room for improvement
in the clinical treatment of cancer.
In an effort to improve these current cancer treatments, medical researchers have worked
tirelessly to devise alternative means of combating cancer with treatments with less negative side
effects. After much research, scientists have finally pinpointed a viable option that could be
exploited in order to effectively treat cancer patients. For the past fifteen years, scientists have
studied the process of RNA interference for a better answer. More specifically, these biochemists
have conducted numerous experiments in order to study the role of small interfering RNA
1

(siRNA) molecules in the process. Because RNA interference controls genes and their activities
within living cells, this study has opened new doors for cancer research. By delivering these
small interfering RNA molecules to a certain gene in a specific cell, medical researchers can
observe, record, and analyze the effects on the cell due to the gene’s suppression. With these
effects of gene suppression in mind, these researchers can manipulate small interfering RNA to
target specific genes in order to eliminate cancerous cells.
Originally, the research goal was to prepare gold nanoparticle-polyethyleneimine
(AuPEI) conjugates that could be loaded with small interfering RNA molecules. These AuPEIsiRNA conjugates would have been specifically designed to target the CASP8AP2 gene linked to
the inhibition of caspase 8 in apoptosis, or programmed cell death, in human nasopharyngeal
epidermoid carcinoma cells (KB cells).(7) With the principle of RNA interference in mind, these
small interfering RNA molecules can suppress or “knock down” the expression of this
CASP8AP2 gene. After analyzing the AuPEI-siRNA conjugate’s ability to enter the KB cells
and its suppression of the CASP8AP2 gene, these effects could be further studied in order to
apply this concept to the expression of folate receptors in cancer cells. With the use of folate
receptor expression, the process of apoptosis can manipulated in order to efficiently reduce
and/or effectively eliminate cancer cells.
During the Fall 2011 semester at the University of Southern Mississippi, the Huang
research group successfully conducted experiments in order to characterize these gold
nanoparticles (AuNPs) by its ultra-violet (UV) absorbance and its zeta (ζ) potential. However,
towards the end of the semester, the research group experienced multiple incidences of
aggregation during the steps of PEI coating and tRNA loading. These observations suggested
that the PEI concentration used in the AuNP coating step could have reached its saturation point.
2

Therefore, with these problems in mind, the Spring 2012 semester of research was geared
towards determining the optimal PEI concentration for the synthesis of AuPEI conjugates. More
specifically, the research effort was designed to explore how many PEI molecules are bound to
each gold nanoparticle. By designing a C12PEI solution incorporated with fluorescein
isothiocyanate (FITC), the Huang research group was able to gain a close look into the synthesis
of the AuPEI-FITC conjugates. By monitoring the fluorescence of these conjugates, the results
could provide information about optimal synthesis conditions. Throughout the semester, the
Huang research group conducted experiments to study the effects of incubation time,
temperature, and dithiothreitol (DTT) concentration on the amount of PEI-FITC on each gold
nanoparticle. These series of experiments were conducted in order to determine the quantity of
PEI molecules attached to the gold nanoparticle. Upon determining the amount of PEI molecules
on each gold nanoparticle, the Huang research proceeded into Summer 2012 semester, seeking
the goal of optimizing the system for adding tRNA molecules to the AuPEI conjugates. Once the
optimized system for AuPEI-tRNA assembly has been established, future research efforts will be
able to use siRNA molecules cost-effectively when preparing the final AuPEI-siRNA conjugates
for the cell study phase of this project.
Chapter 2: Literature Review
RNA interference (RNAi) is a biological system within living cells that controls genes
and their activities. The process of RNAi revolves around the functionality of two small RNA
molecules: small interfering RNA (siRNA) and micro RNA (miRNA). It is known that siRNA
and miRNA have the ability to bind with other types of RNA, while controlling the activity of
specific genes. More specifically, siRNA can bind with specific messenger RNA (mRNA)
molecules to prevent them from certain proteins that are harmful to living cells.(12)
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The process of RNAi occurs in many eukaryotic organisms. During this process, the
enzyme Dicer breaks down complex, double-stranded RNA molecules into smaller nucleotides.
Next, these siRNA molecules are broken down into single-stranded RNA molecules. These two
single-stranded RNA molecules are often referred to as the passenger (sense) strand and the
guide (anti-sense) strand. While the passenger (sense) strand will break down, the guide (antisense) strand will enter the RNA-induced silencing complex (RISC). When the guide strand
binds with a complementary fragment of an mRNA molecule, it can lead to post-transcriptional
gene silencing. The RNAi mechanism, outlined
in Figure 1, has shown much promise related to
Figure 1: RNA
Interference
Pathway(14)

research in various scientific fields of study
such as biochemistry, genetics, molecular
biology, and medicine. Based on previous
research efforts, researchers determined that
laboratory synthesized siRNA molecules can be
introduced in vitro to a living cell. Upon
insertion, these siRNA molecules will induce a
partial or complete suppression of a specific

cell. More importantly, the function of each gene in a particular organism can be determined by
analyzing the effects caused by the suppression of the targeted gene expression. This process can
also aid in pinpointing the specific components required for a certain process to occur within a
living cell.(12)
Despite the promise foreseen by the exploitation of the RNAi mechanism in cancer
treatment research, there are several problems involving the delivery of siRNA molecules to a
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particular gene in a living cell. First of all, these siRNA molecules are very unstable. From
previous research conducted at the University of Regensburg, it was determined that siRNA
molecules have a very short half-life, ranging from several seconds to one minute. With this
problem in mind, researchers realize that there is a very small time frame to deliver these siRNA
molecules to a specific destination within a living cell. Another problem with the delivery of
these siRNA molecules involves the difficult task of delivering the proper segment of siRNA to
its complementary segment of mRNA for the specific gene in a living cell. The key to an
efficient delivery of these siRNA molecules is defined by the correct interaction with the cell
membrane. In eukaryotic organisms, there are numerous entryways into each specific type of
cell. With this in mind, these entryways are highly selective based what is being delivered into
the cell. For the majority of these cellular entryways, they will vary in selectivity based on the
size and the type of cargo. Due to the high selectivity observed in cellular entryways, they will
control whether or not these siRNA molecules will be delivered to the specific site. They will
also control the efficiency of the siRNA molecule delivery as well.(1) (6)
With these problems in mind, researchers at the University of Regensburg discovered that
small, mono-disperse nanoparticles with a certain zeta (ζ) potential and surface chemistry should
be used in the delivery of siRNA molecules to a specific location with a living cell.(1) Before this
discovery, researchers tested a side variety of carriers in hope that they would bind with siRNA
molecules to form complexes.(11) For example, researchers used polyethyleneimines and nucleic
acids to synthesize nanoparticles capable for efficiently delivering siRNA molecules. However,
this system produced several problems for the delivery of siRNA molecules. First of all, this
system produced nanoparticles that were too large for entry into a living cell. Often, these
nanoparticles were measured to be larger than 100 nanometers. More importantly, this system
5

also produced a heterogenous mixture of different nanoparticle species. Due to the wide variety
of nanoparticle possibilities generated from this system, researchers were not able to determine
which species caused these effects within the living cells. Finally, this system produced a small
amount of nanoparticle species which left behind residual toxic effects within the living cells
tested in these experiments.(1) Based on the problems observed in these previous systems, it has
opened new doors, in terms of research, to find an effective transport vehicle for delivering
siRNA molecules. Research-renowned scientists, Gregory Schneider and Gero Decher, have
described nanoparticle research as a “boom topic” in the

Figure 2: Gold Nanoparticle Solution(13)

fields of colloid and material sciences.(4)
In the past decade, researchers have conducted
numerous experiments in order to study the characteristics
and synthesis of gold nanoparticles, which have been
pinpointed as a potential transport vehicle for delivering
siRNA molecules to specific locations within in a living
cell.(2) Before this important research discovery, gold
nanoparticles were only used for transporting plasmid
DNA and oligonucleotides into cells. When compared to free siRNA complexes, these
conjugates produce a six-fold increase in the half-life of siRNA molecules. They have also
provided experimental data, suggesting that these conjugates can increase the knockdown rates
for gene expression. Shown in Figure 2, gold nanoparticles are considered to be the ideal
transport vehicle for delivering siRNA molecules to specific destinations within a living cell.
First of all, these gold nanoparticles can be easily synthesized and modified to fit certain
requirements. Next, they are readily available in numerous sizes and shapes, which allow them to
6

fit into specific entryways of living cells. These gold nanoparticles are also highly biocompatible
with living cells and tissues within eukaryotic organisms. More specifically, unlike previous
nanoparticle synthesis systems, these small gold nanoparticles, ranging from fourteen to sixteen
nanometers, are produced in a homogenous mixture that is free of aggregation. This eliminates
problem that involves the inability to enter a living cell due to its size and cargo. It minimizes
the inability to determine which nanoparticle species suppressed the specific gene in the
experimental cell, which is caused by a heterogenous mixture of different nanoparticle species.(1)
However, before conjugating these gold nanoparticles with siRNA molecules, the gold
nanoparticles must be coated with a branched polyethyleneimine (PEI) solution in order to
enhance the stability of the
entire conjugate. AuPEI
conjugates are commonly
assembled through the layerby-layer (LbL) approach. This
process “uses two solutions of

Figure 3: Branched Polyethyleneimine Structure(5)

oppositely charged polymers into which the substrate (AuNP) surface can be dipped”. (3)
“Sequential dipping causes material to be deposited on the surface because of electrostatic and
hydrophobic interactions between the charged surface and polyelectrolyte. Once deposited, the
layer of polyelectrolyte
inverts the surface
charge of the material it
Figure 4: Preparation of AuPEI Conjugates(18)

is adsorbed to, enabling
a subsequent layer of
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polymer to be deposited from the second solution”.(3) More importantly, the layer-by-layer
approach “can be repeated indefinitely to form a uniform multi-layered film of polymeric
material”.(3) As shown in Figure 3, PEI is a highly branched polymer with nearly twenty-five
percent primary amine groups, fifty percent secondary amine groups, and twenty-five percent
tertiary amine groups.(11) These branched PEI molecules also contain a C12 linker which is
manipulated by thiol chemistry to bind with these gold nanoparticles. These PEI molecules act as
a “reductant and stabilizer”, which allows siRNA molecules to bind at the “appropriate weight
ratio” based on their “electrostatic interaction” with each other. As shown in Figure 4, once the
siRNA molecules are bound with the AuPEI conjugates, the product is formed into a “welldispersed nanoparticle with uniform structure and narrow size distribution.” At the University of
Science and Technology of China Hefei, the Song research group determined that these AuPEIsiRNA conjugates were responsible for increasing the gene knockdown of the green fluorescent
protein found in MDA-MB-435s cells. This same research effort also discussed that these
AuPEI-siRNA conjugates were responsible for increasing the gene knockdown of endogenous
cell-cycle kinase, while also initiating cell apoptosis as well. More importantly, along with these
impressive results, these AuPEI-siRNA conjugates proved to have no toxic effects on normal
cells.(8)
In order to quantify the exact amount of PEI molecules on each gold nanoparticle, the
Huang research group enlisted the aid of two common chemical solutions used in the laboratory,
fluorescein isothiocyanate (FITC) and dithiothreitol (DTT), seen in Figure 5 and 6 respectively.
FITC is a fluorescent dye incorporated in the PEI solution, which is used to coat the gold
nanoparticles before assembling the conjugates with siRNA molecules. This dye absorbs
ultraviolet light around the wavelength of 492 nanometers, while emitting visible light around
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the wavelength of 518 nanometers.(10) The use of the FITC dye is ideal because its absorption
and emission wavelengths are not similar with the wavelengths at which the AuPEI conjugates
will absorb and emit ultraviolet light.

Figure 6: Chemical Structure of DTT(15)

Figure 5: Chemical Structure of FITC(16)
More specifically, there should not be any interference in the graphs when these AuPEI-FITC
conjugates are characterized by ultraviolet spectroscopy. By incorporating FITC into these
AuPEI conjugates, this dye could be tracked by its fluorescent signal, which is measured and
collected by a fluorometer. However, a thiol-exchange reaction must occur before measuring the
fluorescent signal of an AuPEI-FITC solution sample. This thiol-exchange reaction mechanism
is outlined below in Figure 7. For a given AuPEI-FITC sample, the solution is treated with a
certain concentration of DTT, which is a strong reducing agent for breaking disulfide bonds. In
the presence of DTT, this reagent will break the disulfide bonds between the gold nanoparticles
and branched PEI-FITC molecules. The gold nanoparticles will bind with DTT, thus producing
clearly visible signs of aggregation. On the other hand, the PEI-FITC molecules will release
freely into the supernatant of the solution, which can be extracted and measured for its
fluorescent signal. With this in mind, the Huang research group studied the DTT concentration
effect on fluorescent signal, while devising different incubation temperatures, incubation time
periods, and DTT concentrations in order to provide data parameters t hat were used to quantify
the amount of PEI molecules on each gold nanoparticle.
9

Figure 7: Determination of PEI Density(17)

Chapter 3: Methodology
Preparation & Characterization of AuPEI-FITC Conjugates
Two parallel solution samples of AuPEI-FITC conjugates were prepared by adding 100
μL of 15 nM AuNP solution (synthesized by Dr. Huang)(19) and 2.5 μL of 40 mM C12PEI-FITC
solution (synthesized by Dr. Huang)(20) into a 1.5 mL cuvette. After preparing the solutions in
their respective cuvettes, they were incubated at room temperature for ten minutes, followed by
an incubation period of ten minutes in the 65˚C heat block. After incubation, these two solutions
of AuPEI-FITC were centrifuged at “full speed” (14,000 rpm) for thirty minutes in the
Eppendorf Centrifuge 5415D. After centrifugation, the supernatant of each solution was
removed, while maintaining the integrity of the pellet. Next, the pellet in each solution was resuspended with 1,000 μL of pure water. It is important to note that the steps of centrifugation,
washing, and re-suspension were repeated five times during this stage of the experiment. The lab
group saved the supernatant of each washing in a separate cuvette for future procedures. Once
each solution was re-suspended for the fifth time, both solutions were characterized by
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ultraviolet (UV) spectroscopy with the use of the Hewlett Packard Agilent 8453 UV/VIS
Spectrophotometer. During the UV characterization, a blank cuvette filled with 500 μL of water
was tested by this instrument in order to balance the absorbance readings. Next, the sample
cuvette filled with 500 μL of water and 10 μL of the AuPEI-FITC solution was tested by this
instrument in order to determine its λmax and absorbance reading. The data collected during the
UV characterization was recorded into the Microsoft Excel software program for further data
analysis.
Determination of PEI Density (DTT Concentration Effect on Fluorescent Signal)
In order to determine the DTT concentration effect on fluorescent signal, three control
C12PEI-FITC solution samples with no DTT concentration were prepared along with eight
C12PEI-FITC solutions with DTT concentrations of 20 mM, 50 mM, 100 mM, 200 mM, 500
mM, 1,000 mM, 1,200 mM, and 1,500 mM. These solution samples were prepared with stock
solutions of 1.0 μM C12PEI-FITC, 200 mM DTT, 2.0 M DTT, and pure water. The table below
outlines the specific volumes of each solution required to prepare these samples.
1.0 μM C12PEI-FITC 200 mM DTT Pure Water
Control 1
7.0 μL
0.0 μL
63.0 μL
Control 2
7.0 μL
0.0 μL
63.0 μL
Control 3
7.0 μL
0.0 μL
63.0 μL
Sample 1
Sample 2
Sample 3

7.0 μL
7.0 μL
7.0 μL

7.0 μL
17.5 μL
35.0 μL

Sample 4
Sample 5
Sample 6
Sample 7
Sample 8

1.0 μM C12PEI-FITC
7.0 μL
7.0 μL
7.0 μL
7.0 μL
7.0 μL

2.0 M DTT
7.0 μL
17.5 μL
35.0 μL
42.0 μL
52.5 μL
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56.0 μL
45.5 μL
28.0 μL

[DTT]
0 mM
0 mM
0 mM
20 mM
50 mM
100 mM

Pure Water
[DTT]
200 mM
56.0 μL
500 mM
45.5 μL
1,000 mM
28.0 μL
1,200 mM
21.0 μL
1,500 mM
10.5 μL

After preparing these samples, each sample cuvette was spun by the Vortex Genie 2 for
ten seconds in order to ensure a homogenous solution. After this step, a 60 μL aliquot of each
sample was added into a cuvette in order to measure its fluorescent signal with the help of the
PTI FRET Master Fluorometer. The fluorescent signal data collected during this stage in the
experiment was recorded into the Microsoft Excel software program for future data analysis.
Determination of PEI Density (Temperature Effect)
Incubation Table
Sample #1 Sample #2 Sample #3
RT (Room Temperature) 30 minutes
1 hour
2 hours
Control Sample (70˚C) 10 minutes 20 minutes 40 minutes
10 minutes 20 minutes 40 minutes
Test Sample (70˚C)
First of all, a series of three control samples were prepared by adding 10 μL of 1.0 μM
C12PEI-FITC solution and 10 μL of 200 mM DTT solution into a 1.5 milliliter cuvette. These
control samples were incubated in the 70˚C heat block for the allotted times of 10, 20, and 40
minutes, which follows according to the previously outlined incubation table. After its respective
incubation period, 80 μL of pure water was added into each cuvette in order to prepare an
adequate amount of solution for future testing procedures. Next, each solution cuvette was
centrifuged in the Eppendorf Centrifuge 5415D at “full speed” for thirty minutes. After
centrifugation, a 70 μL sample of the supernatant was removed from the solution and saved in
another cuvette for future test procedures. From this sample, a 60 μL aliquot was inserted into a
cuvette in order to measure its fluorescent signal with the use of the PTI FRET Master
Fluorometer. Finally, the lab group tested for aggregation by attempting to re-suspend the pellet
and excess supernatant into a homogenous solution. The fluorescent signal data from these
samples were recorded into the Microsoft Excel software program for future data analysis.
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Secondly, a series of three 70˚C test samples were prepared by adding 10 μL of AuPEIFITC solution and 10 μL of 200 mM DTT solution into a 1.5 milliliter cuvette. These test
samples were incubated in the 70˚C heat block for the allotted times of 10, 20, and 40 minutes,
which also follows the directions provided in the previously outlined incubation table. After its
respective incubation period, the lab group added 80 μL of pure water into each cuvette in order
to prepare enough solution for testing in the later procedures. Next, each solution cuvette was
centrifuged at full speed for thirty minutes. After centrifugation, a 70 μL sample of the
supernatant was removed from the solution and stored in another cuvette for testing in later
procedures. Again, a 60 μL supernatant aliquot was inserted into a cuvette in order to measure its
fluorescent signal with the aid of the PTI FRET Master Fluorometer. Next, an aggregation test
was performed on the original cuvette by attempting to re-suspend the pellet and excess
supernatant into a homogenous solution. Again, the fluorescent signal data from these samples
were recorded into the Microsoft Excel software program for future data analysis.
Thirdly, a series of three room temperature test samples were prepared by adding 10 μL
of AuPEI-FITC solution and 10 μL of 200 mM DTT solution into a 1.5 milliliter cuvette. These
test samples were incubated at room temperature for time periods in the range of 30 minutes, 1
hour, and 2 hours. These time periods follow accordingly to the previously outlined incubation
table. After each incubation period, 80 μL of pure water was added into each cuvette in order to
secure enough solution for further testing procedures. Next, each solution cuvette was
centrifuged in the Eppendorf Centrifuge 5415D at “full speed” for thirty minutes. After
centrifugation, a 70 μL sample of the supernatant was removed from the solution and saved in
another cuvette for future testing procedures. From this sample, a 60 μL supernatant aliquot was
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added to a cuvette in order to measure its fluorescent signal by using the PTI FRET Master
Fluorometer. Again, an aggregation test was performed on the original solution cuvette by
attempting to re-suspend the pellet and excess supernatant into a homogenous mixture. The
Microsoft Excel software program was used again in order to record and analyze the fluorescent
signal data.
In addition to these samples, two additional control samples were prepared in order to
provide more accurate data when determining the PEI density. For the first additional control, 10
μL of 1.0 μM C12PEI-FITC and 10 μL of pure water was added into a 1.5 milliliter cuvette. After
spinning the control sample with the Vortex Genie 2 for ten seconds, 80 μL of pure water was
added into the cuvette. After a second round of spinning, a 60 μL aliquot of the solution was
inserted into a cuvette in order to measure its fluorescent signal with the use of the PTI FRET
Master Fluorometer. For the first additional control, 10 μL of 1.0 μM C12PEI-FITC and 10 μL of
200 mM DTT were pipetted into a 1.5 milliliter cuvette. After spinning the control sample with
the Vortex Genie 2 for ten seconds, an additional 80 μL of pure water was added into the cuvette
to secure enough solution for future testing procedures. Next, a 60 μL aliquot of the solution was
added into a cuvette in order to measure its fluorescent signal with the use of the PTI FRET
Master Fluorometer. Along with the data from previously prepared samples, the fluorescent
signal data was recorded into the Microsoft Excel software program for future data analysis.
Determination of PEI Density (DTT Concentration Effect)
In order to study the DTT concentration effect on the PEI density, stock solutions of 1.0
M DTT and 2.0 M DTT along with a AuPEI-FITC solution were used to prepare samples with
the final DTT concentration set at 500 mM and 1.0 M. These samples were prepared by adding
14

10 μL of the AuPEI-FITC solution and 10 μL of the 1.0 M or 2.0 M DTT solution. These
prepared samples were incubated under the time parameters outlined in the following table.
Incubation Table
Sample #1 Sample #2 Sample #3 Sample #4 Sample #5
500 mM at 70˚C 10 minutes 20 minutes 30 minutes 40 minutes 60 minutes
10 minutes 20 minutes 30 minutes 40 minutes 60 minutes
1.0 M at 70˚C
After these respective incubation periods, 80 μL of pure water was added into each
sample cuvette. Each sample was spun by the vortex machine for ten seconds before centrifuging
them in the Eppendorf Centrifuge 5415D at “full speed” for thirty minutes. After centrifugation,
70 μL of the supernatant was removed and stored in another cuvette for future testing
procedures. From this sample, a 60 μL aliquot was inserted into the test cuvette in order to
measure the fluorescent signal with the use of the PTI FRET Master Fluorometer. The
fluorescent signal data collected by the fluorometer was recorded into the Microsoft Excel
software program for future data analysis.
Optimization of the AuPEI-tRNA Conjugate Assembly System
The AuPEI-tRNA conjugates were assembled by adding 17.9 μL of 1.64 mM tRNA
solution, 15.9 μL of AuPEI solution, and 821 μL of pure, de-ionized water into a 1-mL tube.
Subsequently, the AuPEI-tRNA solution was equally divided amongst four solution tubes. Upon
adding 250 μL of AuPEI-tRNA into each of the four tubes, each tube was marked at the 20 μL
level for future instructions. Each of these solutions was centrifuged for 80 minutes at 7.0 rpm.
After the first round of centrifugation, the supernatant of each solution sample was removed only
to the level of the 20 μL mark. Upon removal of the supernatant, 180 μL of pure, de-ionized
water was added to each of the sample before undergoing another round of centrifugation for 80
15
15

minutes at 7.0 rpm. Again, the supernatant of each solution sample was removed only to the
level of the 20 μL mark. After removing the supernatant, another 180 μL of pure, de-ionized
water was added to each solution sample in order to have a final volume of 200 μL. Finally, 10
μL of each solution sample and 500 μL of pure, de-ionized water were added into a cuvette in
order to conduct UV absorbance experiments. It is important to note that three trials were
conducted for each of the four solution samples.
Chapter 4: Results
Characterization of AuPEI-FITC Conjugates
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Figure 8: AuPEI-FITC Conjugate UV/Vis Spectra
Table 1: AuPEI-FITC Conjugate Absorbance Data
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DTT Concentration Effect on Fluorescent Signal
Figure 9: Graph displaying the DTT concentration effect on fluorescence
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Figure 10: Graph displaying sample PEI density while incubated at room temperature over 2 hours
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Figure 11: Graph displaying sample PEI density while incubated at 70˚C over 40 minutes
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Figure 12: Graph of sample PEI density in 100 mM DTT and 70˚C incubation over 40 minutes
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Figure 13: Graph of sample PEI density in 1.0 M DTT and 70˚C incubation over 60 minutes
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Figure 14: UV Absorbance Graph and Table for AuPEI-tRNA Reaction #1
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AU(AuPEI)
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Figure 15: UV Absorbance Graph and Table for AuPEI-tRNA Reaction #2
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Figure 16: UV Absorbance Graph and Table for AuPEI-tRNA Reaction #3
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Figure 17: UV Absorbance Graph and Table for AuPEI-tRNA Reaction #4

AuPEI-tRNA Reaction #4
0.04
0.03
UV-visible
0.02
Absorbance (AU)

Trial #1
Trial #2

0.01

Trial #3
0
0

200

400

600

800

1000

Wavelength (nm)

Trial
1
2
3

λmax (tRNA)
260 nm
257 nm
257 nm

AU (tRNA)
3.25904 x 10-2
3.29518 x 10-2
3.44729 x 10-2

λmax (AuPEI)
528 nm
527 nm
528 nm

AU(AuPEI)
2.44756 x 10-2
2.48680 x 10-2
2.53854 x 10-2

AU (800 nm)
1.31989 x 10-3
2.22111 x 10-3
1.27220 x 10-3

Chapter 5: Discussion/Conclusion
Preparation and Characterization of AuPEI-FITC Conjugates
After successfully preparing two parallel solution samples, the Huang research group
suggests that the following parameters are the optimal settings for synthesizing these AuPEIFITC conjugates. In terms of incubation, they suggested that ten minutes at room temperature
and ten minutes at 65˚C ensured the binding of the gold nanoparticles and the PEI-FITC
molecules. In terms of centrifugation, they suggested that centrifuging the samples at “full
speed” for thirty minutes provided them with a well-intact pellet and no signs of the pellet
diffusing into the supernatant of the centrifuged solution. In terms of washing, they suggested
that removing nearly all of the supernatant without harming the pellet and adding 1,000 μL of
pure water ensured the purification of the AuPEI-FITC solution. With no obvious signs of
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aggregation observed during this stage, the Huang research group proceeded towards the
characterization of these AuPEI-FITC conjugates.
During this stage, the Huang research group followed protocol by balancing the UV/VIS
spectrophotometer with a cuvette filled only with distilled water. Once the UV/VIS instrument
was prepared for sample testing, an aliquot of each sample was tested in order to determine the
λmax and absorbance readings for the two parallel AuPEI-FITC solutions. As shown in Figure 8,
both UV/VIS spectra for Sample #1 and #2 followed a similar graphical trend that portrays the
same λmax value and similar absorbance readings. According to Table 1, both Sample #1 and #2
share a λmax value of 537 nanometers, which falls between the expected λmax range values of 534
and 540 nanometers. Also, Sample #1 solution was measured to have an absorbance reading of
2.12913 x 10-2 AU, while the absorbance reading of Sample #2 solution was measured to be
2.83046 x 10-2 AU. This slight change in absorbance between both samples suggests that there
was a potential shift in the background absorbance when testing each sample. However, due to
accurate λmax values and similar absorbance readings, the Huang research group decided that
evidence given during the UV characterization of these AuPEI-FITC conjugates was sufficient
enough to proceed to the steps involving the determination of the PEI density.
DTT Concentration Effect on Fluorescent Signal
Before determining the PEI density on each gold nanoparticle, the Huang research group
decided to observe the effects that DTT concentration might have on the fluorescent signal of
these AuPEI-FITC conjugates. With that in mind, they devised a procedure that would examine
how the fluorescent signal would be affected when the DTT concentration was increased in a
particular solution sample. During this procedure, they used stock solutions of AuPEI-FITC, 200
mM DTT, and 2.0 M DTT in order to prepare individual samples with a range of DTT
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concentrations such as 20 mM, 50 mM, 100 mM, 200 mM, 500 mM, 1,000 mM, 1,200 mM, and
1,500 mM. An aliquot of the supernatant was removed from each sample and tested for any
changes in fluorescent signal. After collecting the fluorescent signal data, it was analyzed with
Microsoft Excel, which provided them with a graph that plotted DTT concentration (x-axis)
versus the ratio of sample/control (y-axis). As shown in Figure 9, the graphical results suggested
that the DTT concentration, indeed, did have an effect on the fluorescent signal of these AuPEIFITC solutions. More specifically, the graphical results suggested that the fluorescent signal
decreased as the DTT concentration increased in each solution. However, the fluorescent signal
only decreased between the range of 20 mM and 500 mM. Beyond that point in the data, it
seemed that there was no loss in fluorescent signal between the DTT concentrations of 500 mM
and 1,500 mM. This observation suggests that these concentrations between 500 mM and 1,500
mM are likely to provide the DTT concentration parameters where the optimal PEI density will
be determined. However, due to the decreasing fluorescent signal trend between 20 mM and 500
mM, it also suggests that PEI density in the following experiments must be corrected for the lost
signal in order to accurately determine the amount of PEI molecules on each gold nanoparticle.
Determination of PEI Density (Temperature Effect)
In order to accurately determine the PEI density on each gold nanoparticle, the Huang
research group devised a procedure that would pinpoint the optimal temperature at which the
most PEI-FITC molecules would release into the supernatant solution when treated with a
constant DTT concentration. During this procedure, they used stock solutions of AuPEI-FITC,
1.0 μM PEI-FITC, and 200 mM DTT in order to prepare the control and test samples that would
be incubated at room temperature and 70˚C. After incubation and centrifugation, an aliquot of
the supernatant was removed from each sample in order to test its fluorescent signal. After
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collecting the fluorescent signal data, it was processed by Microsoft Excel in order to calculate
the correct PEI density for each sample. Again, this software program organized the data into a
graph which plotted incubation time (x-axis) versus PEI density (y-axis). As shown in Figure 10,
the results suggest that a larger amount of time was required for the thiol-exchange reaction to
fully complete in solution. At thirty minutes, the PEI density started around 200 PEI-FITC
molecules per gold nanoparticle. After two hours, the PEI density had only increased to 350 PEIFITC molecules per gold nanoparticles. This graph suggests that the PEI density only increased
minimally over a two hour time span. On the other hand, Figure 11 suggests that a smaller
amount of time was required for the thiol-exchange reaction to fully complete in solution. At ten
minutes, the PEI density started around 350 PEI-FITC molecules per gold nanoparticle. At forty
minutes, the PEI density had increased to 700 PEI-FITC molecules per gold nanoparticle. This
graph suggests that the PEI density had increased more effectively in 70˚C sample trials.
Therefore, the Huang research group has determined that 70˚C is the optimal incubation
temperature at which the thiol-exchange reaction can occur more effectively.
Determination of PEI Density (DTT Concentration Effect)
In a final step towards determining the PEI density of these AuPEI-FITC conjugates, the
Huang research group proposed another procedure that would identify the optimal DTT
concentration at which the most PEI-FITC molecules will release into the supernatant solution
during the thiol-exchange reaction. In this experiment, stock solutions of AuPEI-FITC, 1.0 M
DTT, and 2.0 M DTT were used in order to prepare the test samples that would be incubated at
the previously-determined optimal temperature of 70˚C. After incubation and centrifugation, an
aliquot of the supernatant was removed from each sample in order to test the fluorescent signal.
With the fluorescent signal data on record, the Huang research group used Microsoft Excel to
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calculate the correct PEI density for each sample. Again, this software program was used to
organize this data into graphs that plotted incubation time (x-axis) versus PEI density (y-axis).
After producing these graphs, the Huang research group compared the results in order to
determine the optimal PEI density on each gold nanoparticle. As shown in Figure 12, the graph
suggested that the optimal PEI density could not be clearly determined from its data. In this 100
mM DTT at 70˚C graph, it appeared that the PEI density was continuing to increase through the
measured incubation time range. This observation suggests that the thiol-exchange reaction
needs more time to occur when using a 100 mM DTT solution. However, in Figure 13, the graph
suggests that the optimal PEI density could be determined from its data. Based on the 1.0 M
DTT at 70˚C graph, it appeared that PEI density had reached a plateau mark around 1,000 PEI
molecules per gold nanoparticle. This observation suggests that the thiol-exchange reaction has
fully completed, and the optimal PEI density can be determined when using a 1.0 M DTT
solution.
Optimization of the AuPEI-tRNA Conjugate Assembly System
After two rounds of centrifugation and purification, the Huang research group tested the
UV absorbance and λmax readings for each of the four AuPEI-tRNA solution samples. Based on
previous research data, it was expected to have a λmax for tRNA at 259 nanometers and another
λmax for AuPEI between 528 and 530 nanometers. To compensate for the broad range between
the two λmax points, the wavelength range was adjusted to cover the absorbance data points
between 220 and 800 nanometers. For each of the four solution samples, three UV absorbance
trials were conducted for accuracy and precision purposes. Based on the Reaction #1 data (see
Figure 14), the λmax for tRNA exhibited a range of data points between 252, 257, and 259

25

nanometers, while the λmax for AuPEI was located at 527 and 528 nanometers. For Reaction #2
(see Figure 15), data from the trials suggested the λmax for tRNA to be in the range between 258
and 259 nanometers, while the λmax for AuPEI was located in the close proximity to 528 and 530
nanometers. Based on the Reaction #3 data (see Figure 16), the λmax for tRNA was suggested to
be 258 and 260 nanometers, while the λmax for AuPEI was pinpointed to be 528 and 529
nanometers. For Reaction #4 (see Figure 17), the trial data suggested the λmax for tRNA to be 257
and 260 nanometers, while the λmax for AuPEI was identified to be at 527 and 528 nanometers.
Overall, based on the UV data from these AuPEI-tRNA samples, the λmax values were similar to
the expected λmax values for tRNA and AuPEI. Therefore, it can be concluded that the
centrifugation and purification steps were efficient in producing an optimized system for
assembling AuPEI-tRNA conjugates.
Conclusion
With the results from these procedures in mind, the Huang research group has calculated
the optimal PEI density to be 1,000 PEI molecules per gold nanoparticle. The determination of
PEI density is an important step towards developing these AuPEI-siRNA conjugates that can be
delivered into cancer cells to induce apoptosis by targeting the expression of the CASP8AP2
gene. By knowing the exact amount of PEI on each gold nanoparticle, the Huang research group
could theoretically calculate the amount of tRNA molecules that can be bound to these AuPEI
conjugates. Upon establishing an optimized system for adding tRNA to the AuPEI conjugates,
future research efforts can proceed towards the loading of siRNA molecules onto the AuPEI
conjugates. Once the final AuPEI-siRNA product has been assembled, the Huang research group
can continue into the cell study phase, where they can specifically target the CASP8AP2 gene in
KB cells.
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